APA (7th ed.) Citation

Liao, C., Bai, L., He, T., Liang, Q., Hu, D., Lei, S., . . . Wang, Y. Efficacy and Safety of Chemotherapy or EGFR‐TKIs as First‐Line Therapy in NSCLC Patients Harboring Non‐Ex 20 Ins Uncommon EGFR Mutations: A Retrospective Study in China. Wiley.

Chicago Style (17th ed.) Citation

Liao, Chen, Li Bai, Tingting He, Qingle Liang, Defeng Hu, Shipeng Lei, Yong He, and Yubo Wang. Efficacy and Safety of Chemotherapy or EGFR‐TKIs as First‐Line Therapy in NSCLC Patients Harboring Non‐Ex 20 Ins Uncommon EGFR Mutations: A Retrospective Study in China. Wiley.

MLA (9th ed.) Citation

Liao, Chen, et al. Efficacy and Safety of Chemotherapy or EGFR‐TKIs as First‐Line Therapy in NSCLC Patients Harboring Non‐Ex 20 Ins Uncommon EGFR Mutations: A Retrospective Study in China. Wiley.